The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis

Christos A. Papanastasiou(Aristotle University of Thessaloniki), Theodoros D. Karamitsos(Aristotle University of Thessaloniki), Haralambos Karvounis(Aristotle University of Thessaloniki), Απόστολος Τσάπας(Aristotle University of Thessaloniki), Thomas Zegkos(AHEPA University Hospital), Christopher M. Kramer(American College of Cardiology), Maria-Anna Bazmpani(Aristotle University of Thessaloniki), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Antonios Ziakas(Leiden University Medical Center), Georgios Efthimiadis(Aristotle University of Thessaloniki), Andreas P. Kalogeropoulos(St Thomas' Hospital)
International Journal of Cardiology
August 10, 2022
10.1016/j.ijcard.2022.08.008
Cited by 20

Related Papers

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetologia|2022|986
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
|JACC. Cardiovascular imaging|2013|664